Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/nyas.14506 http://scihub22266oqcxt.onion/10.1111/nyas.14506 33009668!7675607!33009668     free     free     free Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Ann+N+Y+Acad+Sci 2021 ; 1486 (1): 90-111 Nephropedia Template TP {{tp|p=33009668|t=2021. The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis |pdf=|usr=}}{{33009668}} gab.com Text The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis JO: Ann N Y Acad Sci http://www.kidney.de/pget.php?&tw=1&pmid=33009668 #FOAvip Evidence from previous coronavirus outbreaks has shown that infected patients are at risk for developing psychiatric and mental health disorders, such as depression, anxiety, and sleep disturbances. To construct a comprehensive picture of the mental health status in COVID-19 patients, we conducted a systematic review and random-effects meta-analysis to assess the prevalence of depression, anxiety, and sleep disturbances in this population. We searched MEDLINE, EMBASE, PubMed, Web of Science, CINAHL, Wanfang Data, Wangfang Med Online, CNKI, and CQVIP for relevant articles, and we included 31 studies (n = 5153) in our analyses. We found that the pooled prevalence of depression was 45% (95% CI: 37-54%, I(2) = 96%), the pooled prevalence of anxiety was 47% (95% CI: 37-57%, I(2) = 97%), and the pooled prevalence of sleeping disturbances was 34% (95% CI: 19-50%, I(2) = 98%). We did not find any significant differences in the prevalence estimates between different genders; however, the depression and anxiety prevalence estimates varied based on different screening tools. More observational studies assessing the mental wellness of COVID-19 outpatients and COVID-19 patients from countries other than China are needed to further examine the psychological implications of COVID-19 infections. Twit Text FOAVip The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis ????Ann N Y Acad Sci http://www.kidney.de/pget.php?&tw=1&pmid=33009668 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33009668 #FOAvip English Wikipedia <ref>{{Cite pmid|33009668}}</ref> The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis #MMPMID33009668 Deng J; Zhou F; Hou W; Silver Z; Wong CY; Chang O; Huang E; Zuo QK Ann N Y Acad Sci 2021[Feb]; 1486 (1): 90-111 PMID33009668show ga Evidence from previous coronavirus outbreaks has shown that infected patients are at risk for developing psychiatric and mental health disorders, such as depression, anxiety, and sleep disturbances. To construct a comprehensive picture of the mental health status in COVID-19 patients, we conducted a systematic review and random-effects meta-analysis to assess the prevalence of depression, anxiety, and sleep disturbances in this population. We searched MEDLINE, EMBASE, PubMed, Web of Science, CINAHL, Wanfang Data, Wangfang Med Online, CNKI, and CQVIP for relevant articles, and we included 31 studies (n = 5153) in our analyses. We found that the pooled prevalence of depression was 45% (95% CI: 37-54%, I(2) = 96%), the pooled prevalence of anxiety was 47% (95% CI: 37-57%, I(2) = 97%), and the pooled prevalence of sleeping disturbances was 34% (95% CI: 19-50%, I(2) = 98%). We did not find any significant differences in the prevalence estimates between different genders; however, the depression and anxiety prevalence estimates varied based on different screening tools. More observational studies assessing the mental wellness of COVID-19 outpatients and COVID-19 patients from countries other than China are needed to further examine the psychological implications of COVID-19 infections. |*Pandemics[MESH] |*SARS-CoV-2[MESH] |Anxiety/epidemiology/*etiology[MESH] |COVID-19/*complications/psychology[MESH] |Depression/epidemiology/*etiology[MESH] |Female[MESH] |Humans[MESH] |Male[MESH] |Mental Health[MESH] |Prevalence[MESH]The prevalence of depression, anxiety, and sleep disturbances in COVID(epmc).pdf DeepDyve Pubget Overpricing